Biogen’s experimental Alzheimer’s drug targets tau protein
WASHINGTON (AP) — An experimental drug might help slow early Alzheimer’s disease in a markedly different way than…
Best Healthcare Stocks to Buy in 2026
Biogen (NASDAQ: BIIB) and Novo Nordisk (NYSE: NVO) represent different opportunities within the healthcare sector: One is a…
Medicare spending far less than expected on new Alzheimer’s drugs
Bob Herman covers health insurance, government programs, hospitals, physicians, and other providers — reporting on how money influences…
Genetic inflammatory signature defines depression subtypes and treatment response
Researchers led by Prof. Alessandro Serretti at Kore University of Enna have identified a genetic inflammatory signature that…
Largest study of African American brain tissue reveals key Alzheimer gene activity
The prevalence of Alzheimer disease (AD) is approximately two times higher in African Americans (AA) compared to White/European-ancestry…
US FDA declines to approve higher dose of Biogen’s genetic disorder drug
(Reuters) -The U.S. Food and Drug Administration has declined to approve a higher-dose version of Biogen’s drug for…